Sophie Vieujean

[Kenneth Rainin Foundation @KR_Foundation]

Dr. Saurabh Mehandru of @MehandruLab @IcahnMountSinai is presenting on B cell dysfunction in inflammatory bowel diseases. #InnovationsSymposium2025

[John Damianos, M.D. @john_damianosMD]

Mechanisms of action of approved and investigatory medications for inflammatory bowel disease.

#MedTwitter #GITwitter #IBD

https://t.co/FZFi8moCDv

[Nature Reviews Gastroenterology & Hepatology @NatRevGastroHep]

New online! Understanding the therapeutic toolkit for inflammatory bowel disease https://t.co/Af7BOule87

[Maria Chaparro @maria_chs]

Very honored to be part of the #ECCO guidelines in UC as coordinator @jp_gisbert, working group leader @maria_chs and participant @MJCasanovaG from @EIILaPrincesa. We will do our best to produce a practical tool with an outstanding team

[IHU INFINY @IHU_Infiny]

📢 #AppelACommunications - Ne manquez pas l'opportunité de présenter vos travaux au colloque de l'IHU Infiny le 14 novembre. Soumettez vos abstracts avant le 15 octobre👉 https://t.co/GZNZ5MDd2H #MICI #Recherche #Innovation #Santé

[IHU INFINY @IHU_Infiny]

📢@IHU_Infiny has just just released the first practical guide on using #Methotrexate in #IBD. Great to see options expanding for those battling this challenging condition! 📘💉 #IBDResearch #CrohnsDisease @peyrinbiroulet @Sash_Honap #BCaron https://t.co/ff1l9LbVKH

[IHU INFINY @IHU_Infiny]

🔬Congrats to @sash_honap, @PeyrinBiroulet from INFINY #IBD Institute, and their partners @silvio_silvio75 and @vipuljairathon on their new article in @NatRevDrugDisc!
🚀Let’s keep pushing boundaries!
@CHRU_de_Nancy @Univ_Lorraine @Inserm @InsermEst @Grand_Nancy @IDplusLorraine

[Sophie Vieujean @SVieujean]

Thank you @ECCO2024 for the fantastic conference! Brillant talks, inspirational vibes and new friends. Happy and proud to be part of the @birdgroup_be family and to have such an amazing colleague as national representative @TrianaLobaton

[Laurent Peyrin-Biroulet @PeyrinBiroulet]

Interesting study from the @IOIBD1

"Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD"

https://t.co/S18Zi9CC8B

[GETAID @PGetaid]

🚨 @PGetaid at #UEGWeek 🚨
#BCaron presenting the CURE prospective study.
50% of CD patients still in deep remission 1 year after adalimumab withdrawal in patients with early CD.
@PeyrinBiroulet @MatFume

[Pascal Juillerat MD MSc, IBD specialist @PascalJuillerat]

@TrianaLobaton @birdgroup_be @SVieujean Thank you for your presence and the good discussion , and welcome to Sophie.

[Sophie Vieujean @SVieujean]

@TrianaLobaton A great meeting and encounters ! Thank you @TrianaLobaton for the warm welcome ! So happy to share this experience and NR role with you !

[Therapeutic Advances in Gastroenterology @TAGastroenterol]

Precision medicine in inflammatory bowel disease aims to personalise treatments based on predictive factors, clinical biomarkers, and treatment response indicators. Learn more in this review by @SVieujean and Edouard Louis #PrecisionMedicine #IBD https://t.co/2unisa2X7W

[Hailiang Huang @hailianghuang]

Our latest paper in ⁦@NatureGenet⁩ on IBD genetic architecture across E Asian and European ancestries. A collaboration with Han, Ruize, Kyuyoung, Yoichi, @ZhanjuL, @FinnGen_FI, and IIBDGC #genetics #IBD ⁦@broadinstitute⁩ ⁦@CGM_MGH⁩ https://t.co/1ZytSCS28u

[Laurent Peyrin-Biroulet @PeyrinBiroulet]

Food avoidance and fasting in patients with inflammatory bowel disease.
https://t.co/iaLBZXFYyl

[Laurent Peyrin-Biroulet @PeyrinBiroulet]

Bowel urgency: lessons for IBD trials!

https://t.co/5SF8wTh1Ke

[Marta Calvo Moya @MartaCalvo12]

Hot and relevant topics in #IBD. IBD patients have a poor knowledge about the impact of IBD on fertility and pregnancy and health care professionals do not sufficiently inform their patients. Let’s go! We need to improve. Thank you ⁦@SVieujean⁩ https://t.co/F71duo2wFh